Medipost Obtains Patent for Composition Related to Degenerative Arthritis Treatment in Canada

[Asia Economy Reporter Minji Lee] Medipost announced on the 21st that it has obtained a patent from the Canadian Intellectual Property Office for a composition for treating cartilage damage, cartilage degeneration, cartilage defects, and degenerative arthritis. The company stated, "It can be applied to the production and use of Cartistem."